Sign up to save your podcasts
Or
Share Improving Patient Outcomes with New Approved Drugs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Improving Patient Outcomes with New Approved Drugs
Join Chris Willis, Manager of Discovery and Translational Sciences at Clarivate Analytics, as he talks about immuno-oncology, why it is promising for cancer patients and how it continues to evolve. Learn more about the new approved drugs on the market that treat indications of cancer and the way in which Clarivate Analytics supports the research taking place in this exciting new area.
View all episodes
By Clarivate Analytics – Formerly the IP&Science business of Thomson ReutersJoin Chris Willis, Manager of Discovery and Translational Sciences at Clarivate Analytics, as he talks about immuno-oncology, why it is promising for cancer patients and how it continues to evolve. Learn more about the new approved drugs on the market that treat indications of cancer and the way in which Clarivate Analytics supports the research taking place in this exciting new area.